A randomized, placebo-controlled study of the immunogenicity of human immunodeficiency virus (HIV) rgp160 vaccine in HIV-infected subjects with ≤400/mm 3 CD4 T lymphocytes (AIDS Clinical Trials Group Protocol 137)

Fred T. Valentine, Smriti Kundu, Patrick A J Haslett, David Katzenstein, Laurel A Beckett, Cathie Spino, Michael Borucki, Margarita Vasquez, Gale Smith, Joyce Korvick, Jonathan Kagan, Thomas C. Merigan

Research output: Contribution to journalArticlepeer-review

43 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized, placebo-controlled study of the immunogenicity of human immunodeficiency virus (HIV) rgp160 vaccine in HIV-infected subjects with ≤400/mm <sup>3</sup> CD4 T lymphocytes (AIDS Clinical Trials Group Protocol 137)'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences